157 related articles for article (PubMed ID: 29578630)
1. Outcomes of radiation therapy of indolent cutaneous B-cell lymphomas and literature review.
Gauci ML; Quero L; Ram-Wolff C; Guillerm S; M'Barek B; Lebbé C; Bagot M; Hennequin C
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1668-1673. PubMed ID: 29578630
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience.
De Felice F; Grapulin L; Pieroni A; Salerno F; D'Elia GM; Pulsoni A; Musio D; Tombolini V
Ann Hematol; 2018 Dec; 97(12):2411-2416. PubMed ID: 30094511
[TBL] [Abstract][Full Text] [Related]
4. De-escalated radiotherapy for indolent primary cutaneous B-cell lymphoma.
Oertel M; Elsayad K; Weishaupt C; Steinbrink K; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):126-131. PubMed ID: 31758232
[TBL] [Abstract][Full Text] [Related]
5. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous indolent B-cell lymphomas - a retrospective multicenter analysis and a review of literature.
Olszewska-Szopa M; Sobas M; Laribi K; Bao Perez L; Drozd-Sokołowska J; Subocz E; Joks M; Zduniak K; Gajewska M; de Nalecz AK; Romejko-Jarosińska J; Kumiega B; Waszczuk-Gajda A; Wróbel T; Czyz A
Acta Oncol; 2021 Oct; 60(10):1361-1368. PubMed ID: 34346830
[No Abstract] [Full Text] [Related]
7. Primary radiation therapy in stage I/II indolent orbital lymphoma - a comprehensive retrospective recurrence and toxicity analysis.
Eze C; Friedrich I; Hadi I; Schmidt-Hegemann NS; Hartoyo SN; Trauth R; Reitz D; Manapov F; Siefert A; Dreyling M; Belka C; Li M
Eur J Haematol; 2022 Jul; 109(1):21-30. PubMed ID: 35276022
[TBL] [Abstract][Full Text] [Related]
8. Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.
König L; Hörner-Rieber J; Bernhardt D; Hommertgen A; Rieken S; Debus J; Herfarth K
Strahlenther Onkol; 2018 May; 194(5):454-461. PubMed ID: 29450588
[TBL] [Abstract][Full Text] [Related]
9. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.
Hoskin P; Popova B; Schofield O; Brammer C; Robinson M; Brunt AM; Madhavan K; Illidge T; Gallop-Evans E; Syndikus I; Clifton-Hadley L; Kirkwood AA
Lancet Oncol; 2021 Mar; 22(3):332-340. PubMed ID: 33539729
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal anomalies in primary cutaneous follicle center cell lymphoma do not portend a poor prognosis.
Abdul-Wahab A; Tang SY; Robson A; Morris S; Agar N; Wain EM; Child F; Scarisbrick J; Neat M; Whittaker S
J Am Acad Dermatol; 2014 Jun; 70(6):1010-20. PubMed ID: 24679486
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous B-cell lymphomas: 2015 update on diagnosis, risk-stratification, and management.
Wilcox RA
Am J Hematol; 2015 Jan; 90(1):73-6. PubMed ID: 25535037
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of extranodal low-grade follicular and marginal zone lymphomas: long-term follow-up of 159 patients.
Elsayad K; Reinartz G; Oertel M; Rehn S; Eismann J; Scobioala S; Berssenbrügge H; Eter N; Weishaupt C; Schmidt HH; Friedrichs B; Grünewald I; Hartmann W; Lenz G; Wardelmann E; Willich N; Eich HT
Strahlenther Onkol; 2020 Feb; 196(2):117-125. PubMed ID: 31732783
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous B-cell lymphomas: 2019 update on diagnosis, risk stratification, and management.
Wilcox RA
Am J Hematol; 2018 Nov; 93(11):1427-1430. PubMed ID: 30039522
[TBL] [Abstract][Full Text] [Related]
14. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University.
Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P
Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900
[TBL] [Abstract][Full Text] [Related]
15. Extent of skin involvement as a prognostic indicator of disease free and overall survival of patients with T3 cutaneous T-cell lymphoma treated with total skin electron beam radiation therapy.
Quiros PA; Kacinski BM; Wilson LD
Cancer; 1996 May; 77(9):1912-7. PubMed ID: 8646693
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
Tsang RW; Gospodarowicz MK
Hematol Oncol; 2005 Mar; 23(1):10-7. PubMed ID: 16158458
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy.
Goda JS; Gospodarowicz M; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Tsang RW
Cancer; 2010 Aug; 116(16):3815-24. PubMed ID: 20564130
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous follicle center lymphoma in a 16-year-old girl.
Edmonds N; Hernández-Pérez M; Holsinger M; Gru AA
J Cutan Pathol; 2021 May; 48(5):663-668. PubMed ID: 33326136
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous B-cell lymphomas - clinicopathological, prognostic and therapeutic characterisation of 54 cases according to the WHO-EORTC classification and the ISCL/EORTC TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome.
Golling P; Cozzio A; Dummer R; French L; Kempf W
Leuk Lymphoma; 2008 Jun; 49(6):1094-103. PubMed ID: 18569636
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
